<DOC>
	<DOCNO>NCT00312130</DOCNO>
	<brief_summary>This exploratory study ass whether vildagliptin , unapproved drug , increase insulin secretion subject pre-diabetes defect insulin response elevate level fast glucose .</brief_summary>
	<brief_title>A Study Evaluate Effects Vildagliptin Insulin Response Glucose Subjects With Pre-diabetes</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>BMI range 2245 stable weight last 6 month Blood glucose criterion must meet Written informed consent Pregnancy lactation Previous diagnosis type 2 diabetes treatment hypoglycemic agent Type 1 diabetes Evidence cardiovascular complication define protocol Evidence diabetic complication define protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Vildaglptin</keyword>
	<keyword>Pre-diabetes</keyword>
</DOC>